Annual Retained Earnings
-$102.62 M
-$13.95 M-15.73%
December 1, 2024
Summary
- As of March 10, 2025, CMMB annual retained earnings is -$102.62 million, with the most recent change of -$13.95 million (-15.73%) on December 1, 2024.
- During the last 3 years, CMMB annual retained earnings has fallen by -$66.45 million (-183.70%).
- CMMB annual retained earnings is now -333.10% below its all-time high of -$23.70 million, reached on December 31, 2020.
Performance
CMMB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$102.62 M
-$2.96 M-2.97%
December 1, 2024
Summary
- As of March 10, 2025, CMMB quarterly retained earnings is -$102.62 million, with the most recent change of -$2.96 million (-2.97%) on December 1, 2024.
- Over the past year, CMMB quarterly retained earnings has stayed the same.
- CMMB quarterly retained earnings is now -333.10% below its all-time high of -$23.70 million, reached on December 31, 2020.
Performance
CMMB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CMMB Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.7% | 0.0% |
| 3 y3 years | -183.7% | 0.0% |
| 5 y5 years | -333.1% | 0.0% |
CMMB Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -183.7% | at low | -183.7% | at low |
| 5 y | 5-year | -333.1% | at low | -333.1% | at low |
| alltime | all time | -333.1% | at low | -333.1% | at low |
Chemomab Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$102.62 M(+15.7%) | -$102.62 M(+3.0%) |
| Sep 2024 | - | -$99.66 M(+3.6%) |
| Jun 2024 | - | -$96.18 M(+3.9%) |
| Mar 2024 | - | -$92.55 M(+4.4%) |
| Dec 2023 | -$88.68 M(+39.0%) | -$88.68 M(+10.1%) |
| Jun 2023 | - | -$80.54 M(+11.0%) |
| Mar 2023 | - | -$72.57 M(+13.7%) |
| Dec 2022 | -$63.82 M | -$63.82 M(+14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$55.55 M(+17.0%) |
| Jun 2022 | - | -$47.47 M(+15.0%) |
| Mar 2022 | - | -$41.28 M(+14.1%) |
| Dec 2021 | -$36.17 M(+52.7%) | -$36.17 M(+16.2%) |
| Sep 2021 | - | -$31.14 M(+10.5%) |
| Jun 2021 | - | -$28.17 M(+10.9%) |
| Mar 2021 | - | -$25.40 M(+7.2%) |
| Dec 2020 | -$23.70 M | -$23.70 M |
FAQ
- What is Chemomab Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual retained earnings year-on-year change?
- What is Chemomab Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly retained earnings year-on-year change?
What is Chemomab Therapeutics annual retained earnings?
The current annual retained earnings of CMMB is -$102.62 M
What is the all time high annual retained earnings for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual retained earnings is -$23.70 M
What is Chemomab Therapeutics annual retained earnings year-on-year change?
Over the past year, CMMB annual retained earnings has changed by -$13.95 M (-15.73%)
What is Chemomab Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CMMB is -$102.62 M
What is the all time high quarterly retained earnings for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly retained earnings is -$23.70 M
What is Chemomab Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CMMB quarterly retained earnings has changed by $0.00 (0.00%)